BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 10810746)

  • 21. Investigation of the Effects of Excipients in the Compounding of Amlodipine Besylate Orally Disintegrating Tablets.
    Azmi NHS; Ming LC; Uddin ABMH; Sarker ZI; Bin LK
    Int J Pharm Compd; 2022; 26(1):80-87. PubMed ID: 35081048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new apparatus for real-time assessment of the particle size distribution of disintegrating tablets.
    Quodbach J; Kleinebudde P
    J Pharm Sci; 2014 Nov; 103(11):3657-3665. PubMed ID: 25223505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of granulation on super disintegrant performance.
    Zhao N; Augsburger LL
    Pharm Dev Technol; 2006 Feb; 11(1):47-53. PubMed ID: 16544908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Disintegrants on Prolongation of Tablet Disintegration Induced by Immersion in Xanthan Gum-Containing Thickening Solution: Contribution of Disintegrant Interactions with Disintegration Fluids.
    Sugiura D; Onuki Y; Fujita Y; Nakamura A; Harada T
    Chem Pharm Bull (Tokyo); 2020; 68(11):1055-1060. PubMed ID: 33132372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement by super disintegrants of the properties of tablets containing lactose, prepared by wet granulation.
    van Kamp HV; Bolhuis GK; Lerk CF
    Pharm Weekbl Sci; 1983 Aug; 5(4):165-71. PubMed ID: 6622211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of disintegrant efficacy with fractal dimensions from real-time MRI.
    Quodbach J; Moussavi A; Tammer R; Frahm J; Kleinebudde P
    Int J Pharm; 2014 Nov; 475(1-2):605-12. PubMed ID: 25234864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disintegrant Selection in Hydrophobic Tablet Formulations.
    Bauhuber S; Warnke G; Berardi A
    J Pharm Sci; 2021 May; 110(5):2028-2037. PubMed ID: 33181185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of fast disintegrants in terfenadine tablets containing a gas-evolving disintegrant.
    Sallam E; Ibrahim H; Dahab RA; Shubair M; Khalil E
    Drug Dev Ind Pharm; 1998 Jun; 24(6):501-7. PubMed ID: 9876615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY; Lin KH; Li MJ
    J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of fast disintegrating compressed tablets using amino acid as disintegration accelerator: evaluation of wetting and disintegration of tablet on the basis of surface free energy.
    Fukami J; Ozawa A; Yoshihashi Y; Yonemochi E; Terada K
    Chem Pharm Bull (Tokyo); 2005 Dec; 53(12):1536-9. PubMed ID: 16327184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functionality comparison of 3 classes of superdisintegrants in promoting aspirin tablet disintegration and dissolution.
    Zhao N; Augsburger LL
    AAPS PharmSciTech; 2005 Dec; 6(4):E634-40. PubMed ID: 16408865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disintegration of highly soluble immediate release tablets: a surrogate for dissolution.
    Gupta A; Hunt RL; Shah RB; Sayeed VA; Khan MA
    AAPS PharmSciTech; 2009; 10(2):495-9. PubMed ID: 19387843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mimosa pudica seed mucilage: isolation; characterization and evaluation as tablet disintegrant and binder.
    Ahuja M; Kumar A; Yadav P; Singh K
    Int J Biol Macromol; 2013 Jun; 57():105-10. PubMed ID: 23500434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chitin's Functionality as a Novel Disintegrant: Benchmarking Against Commonly Used Disintegrants in Different Physicochemical Environments.
    Chaheen M; Soulairol I; Bataille B; Yassine A; Belamie E; Sharkawi T
    J Pharm Sci; 2017 Jul; 106(7):1839-1848. PubMed ID: 28392454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fast disintegrating tablets containing Rhodiola rosea L. extract.
    Kucinskaite A; Sawicki W; Briedis V; Sznitowska M
    Acta Pol Pharm; 2007; 64(1):63-7. PubMed ID: 17665852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formulation strategy towards minimizing viscosity mediated negative food effect on disintegration and dissolution of immediate release tablets.
    Zaheer K; Langguth P
    Drug Dev Ind Pharm; 2018 Mar; 44(3):444-451. PubMed ID: 29098885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of Filler Effects on the Compounding of Freeze-dried Orodispersible Tablets Containing Annona muricata Extract.
    Azman SEN; Abd Razak FS; Kamal WHBW; Zheng GK; Ming LC; Uddin AH; Sarker ZI; Bin LK
    Int J Pharm Compd; 2020; 24(6):509-514. PubMed ID: 33217741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A critical review on tablet disintegration.
    Quodbach J; Kleinebudde P
    Pharm Dev Technol; 2016 Sep; 21(6):763-74. PubMed ID: 25975586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of chitosan as a disintegrant on the bioavailability of furosemide tablets: in vitro evaluation and in vivo simulation of novel formulations.
    Rasool BK; Fahmy SA; Galeel OW
    Pak J Pharm Sci; 2012 Oct; 25(4):815-22. PubMed ID: 23009999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formulation and evaluation of nanocrystalline cellulose as a potential disintegrant.
    Wang C; Huang H; Jia M; Jin S; Zhao W; Cha R
    Carbohydr Polym; 2015 Oct; 130():275-9. PubMed ID: 26076627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.